type here...

CATEGORIES

Patient Zone

LATEST

1...424344...60Page 43 of 60

TRENDING

EDITORS CHOICE

Product Recall: Amiodarone HCl Injection, USP and Tranexamic Acid Injection, USP

Medika Life -
Mylan Initiates Voluntary Nationwide Recall of Four Lots of Amiodarone HCl Injection, USP and Tranexamic Acid Injection, USP Due to Carton Label Mix-Up

Does Artificial Intelligence (#AI) Chatbot Outperform Physicians in Patient Experience?

Gil Bashe, Medika Life Editor -
JAMA Article Draws Fire for Its Research Biases on ChatGPT and Chatbot - But Should We Ignore Its Conclusions Altogether?

Drugs are Rapidly Becoming Healthcare’s Greatest Burden

Robert Turner, Founding Editor -
Drugs have become our fallback for almost everything. Practitioners in general are massively guilty of doling them out as a panacea for socially compromised adults. Adults that possess no life skills or coping mechanisms are simply drugged into oblivion.

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

Medika Life -
The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories